Biopharma firm closes $3M Series B round


Miami’s Biscayne Neurotherapeutics closed last week a $3 million Series B financing round to develop its biopharmaceutical assets for the treatment of neurological disorders.

The round was led by San Diego-based VC firm Mesa Verde Venture Partners, Vancouver’s Quark Venture and Chinese securities group GF Securities. Existing investors also participated, along with new private investors.